Literature DB >> 932502

Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.

V G Edy, A Billiau, P De Somer.   

Abstract

In view of the lower physical stability of human fibroblast interferon than of human leukocyte interferon, the rates of clearance of the two types of interferon were compared in vivo. Both types were injected intravenously and intramuscularly into rabbits, and serum titers were determined at various times after injection. The rates of clearance of the two types of interferon were very similar after both intravenous and intramuscular injection, a finding which indicated that, at least in the circulatory system of rabbits, human fibroblast interferon is not less stable than human leukocyte interferon. After intravenous injection of either type, very little interferon was found in soluble extracts of the rabbit liver. This result implies that heterologous interferon is broken down rapidly in the liver, that it is bound to some particulate fraction, or that it does not accumulate in the liver.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932502     DOI: 10.1093/infdis/133.supplement_2.a18

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Heterocomplexes of human interferon and immunoglobulins: formation and properties.

Authors:  K P Fung; M H Ng
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

Review 2.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

3.  Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.

Authors:  J Vilcek; I T Sulea; I L Zerebeckyj; Y K Yip
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

4.  Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.

Authors:  A Billiau; P De Somers; V G Edy; E De Clercq; H Heremans
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

Review 5.  The clinical application of fibroblast interferon--an overview.

Authors:  A Billiau
Journal:  Med Oncol Tumor Pharmacother       Date:  1984
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.